You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hydrochlorothiazide, lisinopril drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,

Not yet recruiting
  • Essential Hypertension
  • Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
  • Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
  • Seoul, Gyeonggi-do, Korea, Republic of
  • +11 more
Sep 11, 2023

Hypertension Trial in Brazil (candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg +

Not yet recruiting
  • Hypertension
  • candesartan cilexetil + chlorthalidone + amlodipine
  • Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
  • Rio Branco, AC, Brazil
  • +21 more
Jun 26, 2023

Hypertension in Pregnancy, Postpartum Preeclampsia Trial in Houston (ACE Inhibitors and Diuretics, NIFEdipine ER)

Recruiting
  • Hypertension in Pregnancy
  • Postpartum Preeclampsia
  • ACE Inhibitors and Diuretics
  • NIFEdipine ER
  • Houston, Texas
    University of Texas Health Science Center
Oct 22, 2021

Bioequivalence Trial in Moscow (Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg, Tritace® Plus tablet 10 mg/25 mg)

Not yet recruiting
  • Bioequivalence
  • Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
  • Tritace® Plus tablet 10 mg/25 mg
  • Moscow, Russian Federation
    Separate medical division "Comed" (Ligand Research LLC)
Jan 5, 2023

Therapeutic Equivalency Trial in Qingdao (compound lisinopril tablet, compound lisinopril tablet(Lisonorm®))

Completed
  • Therapeutic Equivalency
  • compound lisinopril tablet
  • compound lisinopril tablet(Lisonorm®)
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
May 9, 2021

Patients Treated With Telmisartan/Hydrochlorothiazide or

Withdrawn
  • Hypertension
  • subjects treated with telmisartan/hydrochlorothiazide
  • +3 more
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022

Hypertension Trial in Uppsala (Zestril®, Atacand®, Norvasc®)

Completed
  • Hypertension
  • Uppsala, Sweden
    Uppsala University hospital, Internal medicine research, Oscar I
Aug 31, 2021

Micatrio® Combination Tablets Treatment in Hypertension

Completed
Has Results
  • Hypertension
  • T80/A5/H12.5 FDC
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd
May 7, 2020

Hypertension Trial (Losartan 50 mg / HCTZ 12.5 mg)

Completed
Has Results
  • Hypertension
  • Losartan 50 mg / HCTZ 12.5 mg
  • (no location specified)
Feb 7, 2022

Primary Hypertension Trial (Amlodipine, Olmesartan, Hydrochlorothiazide)

Not yet recruiting
  • Primary Hypertension
  • (no location specified)
Jun 15, 2023

Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire

Recruiting
  • Hepatocellular Carcinoma
  • Nonalcoholic Steatohepatitis
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +3 more
Dec 8, 2022

Hypertension Trial in Carrollton (Determine the presence of Human sequence Ang-(1-12) on no medication, Human sequence

Recruiting
  • Hypertension
  • Determine the presence of Human sequence Ang-(1-12) on no medication
  • Human sequence Ang-(1-12) on Lisinopril 40mg every day
  • Carrollton, Texas
    Punzi Medical Center
Dec 6, 2022

Hypertension Trial in Shanghai (losartan/hydrochlorothiazide, amlodipine/hydrochlorothiazide)

Recruiting
  • Hypertension
  • Shanghai, China
    Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
Mar 16, 2021

Mild to Severe Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks,

Completed
  • Mild to Severe Hypertension
  • MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks
  • losartan / Duration of Treatment: 6 weeks
  • (no location specified)
Feb 7, 2022

Diabetes in Adults Trial in Shanghai (Hydrochlorothiazide?Henagliflozin Proline)

Completed
  • Diabetes in Adults
  • Hydrochlorothiazide、Henagliflozin Proline
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 12, 2023

Essential Arterial Hypertension Trial in Mexico City (Losartan/Chlorthalidone in fixed dose, Losartan + hydrochlorothiazide in

Not yet recruiting
  • Essential Arterial Hypertension
  • Losartan/Chlorthalidone in fixed dose
  • Losartan + hydrochlorothiazide in fixed dose
  • Mexico City, Mexico
    Laboratorio Silanes, S.A. de C.V.
Jul 5, 2021

Cardiovascular Disease Trial in Sao Paulo (polipillV1, polipillV2, usual care)

Withdrawn
  • Cardiovascular Disease
  • Sao Paulo, Brazil
    Instituto de Ensino e Pesquisa - IEP - HCor
Sep 20, 2022

Hypertension Trial in Bloemfontein (GSK3542503 (HCTZ 50mg/Amiloride HCl 5mg tablets), Moduretic (HCTZ 50mg/Amiloride HCl 5mg

Completed
Has Results
  • Hypertension
  • GSK3542503 (HCTZ 50mg/Amiloride HCl 5mg tablets)
  • Moduretic (HCTZ 50mg/Amiloride HCl 5mg tablets)
  • Bloemfontein, South Africa
    GSK Investigational Site
May 6, 2021

Resistant Arterial Hypertension Trial in Ryazan (Blood samples will be taken for pharmacokinetics and pharmacogenetics)

Recruiting
  • Resistant Arterial Hypertension
  • Blood samples will be taken for pharmacokinetics and pharmacogenetics
  • Ryazan, Russian Federation
    Ryzan State Medical University
Jun 1, 2023

Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 Trial in Lawrenceville, Bethlehem (Renin-Angiotensin (RAAS) alone,

Recruiting
  • Renal Insufficiency, Chronic
  • Diabetic Nephropathy Type 2
  • Renin-Angiotensin (RAAS) alone
  • Renin-Angiotensin (RAAS) blockers in combination with Spironolactone
  • Lawrenceville, Georgia
  • +1 more
Jan 26, 2022

Hydrochlorothiazide and Risk of Skin Cancer

Completed
  • Non-melanoma Skin Cancer
  • +2 more
  • Montreal, Quebec, Canada
    Centre for Clinical Epidemiology, Lady Davis Institute, Jewish G
Mar 8, 2021

Diabetes, Type 2, Hypertension Trial in Buffalo (carvedilol, lisinopril)

Terminated
  • Diabetes Mellitus, Type 2
  • Hypertension
  • Buffalo, New York
    Diabetes - Endocrinology Center of Western New York
Feb 22, 2022

Renal Insufficiency, Chronic, Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Placebo, Lisinopril)

Recruiting
  • Renal Insufficiency, Chronic
  • Hyperkalemia
  • Sodium Zirconium Cyclosilicate (SZC)
  • +4 more
  • Tucson, Arizona
  • +281 more
Jan 10, 2023

Pediatric Hypertension Trial in Houston (NICHE method, Usual care, Amlodipine)

Completed
Has Results
  • Pediatric Hypertension
  • NICHE method
  • +5 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Aug 16, 2022

Photosensitivity Trial in Homburg (Hydrochlorothiazide, Placebo)

Completed
  • Photosensitivity
  • Homburg, Saarland, Germany
    Saarland University Hospital
Nov 18, 2021